Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model

European Cells and Materials

Volumn 23, Issue , 2012, Pages 400-412

  DeQuach, Jessica A ^a   Lin, Joy E ^a   Cam, Cynthia ^a   Hu, Diane ^a   Salvatore, Michael A ^a   Sheikh, Farah ^b   Christman, Karen L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Extra cellular matrix; Hydrogel; Muscle; Scaffold; Tissue engineering

Indexed keywords

COLLAGEN TYPE 1; DESMIN; MYOD PROTEIN; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAPILLARY DENSITY; CELL INFILTRATION; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; EXTRACELLULAR MATRIX; FEMALE; GELATION; HINDLIMB; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MITOGENESIS; MYOBLAST; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RAT; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; SWINE; TISSUE ENGINEERING; TISSUE REPAIR;

EID: 84865558396     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v023a31     Document Type: Article

References (65)

1. Alev C, Ii M, Asahara T (2011) Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal 15: 949-965.
2. Bach AD, Arkudas A, Tjiawi J, Polykandriotis E, Kneser U, Horch RE, Beier JP (2006) A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med 10: 716-726.
3. Badylak SF (2007) The extra cellular matrix as a biologic scaffold material. Biomaterials 28: 3587-3593.
4. Badylak SF, Gilbert TW (2008) Immune response to biologic scaffold materials. Semin Immunol 20: 109-116.
5. Badylak SF, Park K, Peppas N, McCabe G, Yoder M (2001) Marrow-derived cells populate scaffolds composed of xenogeneic extra cellular matrix. Exp Hematol 29: 1310-1318.
6. Badylak SF, Freytes DO, Gilbert TW (2009) Extra cellular matrix as a biological scaffold material: Structure and function. Acta Biomater 5: 1-13.
7. Banker G, Goslin K (1998) Culturing Nerve Cells, 2nd edition, MIT Press, Cambridge, MA, pp 68-69.
8. Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF (2008) Chemo attraction of progenitor cells by remodeling extra cellular matrix scaffolds. Tissue Eng Part A 15: 1119-1125.
9. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
10. Bhang SH, Kim JH, Yang HS, La WG, Lee TJ, Kim GH, Kim HA, Lee M, Kim BS (2011) Combined gene therapy with hypoxia-inducible factor-1alpha and heme oxygenase-1 for therapeutic angiogenesis. Tissue Eng Part A 17: 915-926.
11. Bruey JM, Kantarjian H, Ma W, Estrov Z, Yeh C, Donahue A, Sanders H, O'Brien S, Keating M, Albitar M (2010) Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leuk Res 34: 1320-1324.
12. Chan YC, Cheng SW (2011) Drug-eluting stents and balloons in peripheral arterial disease: evidence so far. Int J Clin Pract 65: 664-668.
13. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ (2004) In jectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44: 654-660.
14. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS (1999) In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 112: 2895-2901.
15. Crapo PM, Gilbert TW, Badylak SF (2011) An overview of tissue and whole organ decellularization processes. Biomaterials 32: 3233-3243.
16. Dattilo PB, Casserly IP (2011) Critical limb ischemia: endovascular strategies for limb salvage. Prog Cardiovasc Dis 54: 47-60.
17. DeQuach JA, Mezzano V, Miglani A, Lange S, Keller GM, Sheikh F, Christman KL (2010) Simple and high yielding method for preparing tissue specific extra cellular matrix coatings for cell culture. PLoS One 5: e13039.
18. Diniz G, Aktas S, Turedi A, Temir G, Ortac R, Vergin C (2011) Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor. Tumour Biol 32: 761-767.
19. Doi K, Ikeda T, Marui A, Kushibiki T, Arai Y, Hirose K, Soga Y, Iwakura A, Ueyama K, Yamahara K, Itoh H, Nishimura K, Tabata Y, Komeda M (2007) Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia. Heart Vessels 22: 104-108.
20. Fadini GP, Agostini C, Avogaro A (2010) Auto logous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209: 10-17.
21. Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and organs. Biomaterials 27: 3675-3683.
22. Gupta R, Losordo DW (2011) Cell therapy for critical limb ischemia: moving forward one step at a time. Circ Cardiovasc Interv 4: 2-5.
23. Hidestrand M, Richards-Malcolm S, Gurley CM, Nolen G, Grimes B, Waterstrat A, Zant GV, Peterson CA (2008) Sca-1-expressing non myo genic cells contribute to fibrosis in aged skeletal muscle. J Gerontol A Biol Sci Med Sci 63: 566-579.
24. Jay SM, Shepherd BR, Bertram JP, Pober JS, Saltzman WM (2008) Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J 22: 2949-2956.
25. Jeon O, Krebs M, Alsberg E (2011) Controlled and sustained gene delivery from injectable, porous PLGA scaffolds. J Biomed Mater Res A 98: 72-79.
26. Kanisicak O, Mendez JJ, Yamamoto S, Yamamoto M, Goldhamer DJ (2009) Progenitors of skeletal muscle satellite cells express the muscle determination gene, Myo D. Dev Biol 332: 131-141.
27. Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K, Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T (2009) Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27: 2857-2864.
28. Kong HJ, Kim ES, Huang YC, Mooney DJ (2008) Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 25: 1230-1238.
29. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R (1996) Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87: 1069-1078.
30. Kuraitis D, Zhang P, Zhang Y, Padavan DT, McEwan K, Sofrenovic T, McKee D, Zhang J, Griffith M, Cao X, Musaro A, Ruel M, Suuronen EJ (2011) A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 22: 109-123.
31. Lawall H, Bramlage P, Amann B (2010) Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 103: 696-709.
32. Layman H, Spiga MG, Brooks T, Pham S, Webster KA, Andreopoulos FM (2007) The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydro gels on angiogenesis in a murine critical limb ischemic model. Biomaterials 28: 2646-2654.
33. Layman H, Rahnemai-Azar AA, Pham SM, Tsechpenakis G, Andreopoulos FM (2011) Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia. Tissue Eng Part A 17: 243-254.
34. Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150: 1085-1100.
35. Lee J, Bhang SH, Park H, Kim BS, Lee KY (2010) Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system. Pharm Res 27: 767-774.
36. Li F, Li W, Johnson S, Ingram D, Yoder M, Badylak S (2004) Low-molecular-weight peptides derived from extra cellular matrix as chemoattractants for primary endothelial cells. Endothelium 11: 199-206.
37. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extra cellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23: 47-55.
38. Manzi M, Palena L, Cester G (2011) Endovascular techniques for limb salvage in diabetics with crural and pedal disease. J Cardiovasc Surg 52: 485-492.
39. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10: 1173-1183.
40. Menasché P (2010) Cell therapy for peripheral arterial disease. Curr Opin Mol Ther 12: 538-545.
41. Merritt EK, Hammers DW, Tierney M, Suggs LJ, Walters TJ, Farrar RP (2010) Functional assessment of skeletal muscle regeneration utilizing homologous extra cellular matrix as scaffolding. Tissue Eng Part A 16: 1395-1405.
42. Numata S, Fujisato T, Niwaya K, Ishibashi-Ueda H, Nakatani T, Kitamura S (2004) Immunological and histological evaluation of decellu larized allograft in a pig model: comparison with cryopreserved allograft. J Heart Valve Dis 13: 984-990.
43. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA (2008) Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
44. Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E, Bedelbaeva K, McIntosh D, Dewilde A, Braunhut SJ, Badylak SF (2009) Degradation products of extra cellular matrix affect cell migration and proliferation. Tissue Eng Part A 15: 605-614.
45. Rhudy RW, McPherson JM (1988) Influence of the extra cellular matrix on the prolix ferative response of human skin fibroblasts to serum and purified platelet-derived growth factor. J Cell Physiol 137: 185-191.
46. Rieder E, Nigisch A, Dekan B, Kasimir MT, Muhlbacher F, Wolner E, Simon P, Weigel G (2006) Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. Biomaterials 27: 5634-5642.
47. Ruvinov E, Leor J, Cohen S (2010) The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31: 4573-4582.
48. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322.
49. Seif-Naraghi SB, Salvatore MA, Schup-Magoffin PJ, Hu DP, Christman KL (2010) Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A 16: 2017-2027.
50. Silva EA, Mooney DJ (2007) Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5: 590-598.
51. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL (2009) Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 30: 5409-5416.
52. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM, Wang J, Mayle KM, Bartels K, Salvatore M, Kinsey AM, Demaria AN, Dib N, Christman KL (2012) Catheter-deliverable hydro gel derived from decellularized ventricular extra cellular matrix increases endogenous cardio myocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59: 751-763.
53. Sprengers RW, Lips DJ, Moll FL, Verhaar MC (2008) Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann Surg 247: 411-420.
54. Stansby G, Williams R (2011) Angioplasty for treatment of isolated below-the-knee arterial stenosis in patients with critical limb ischemia. Angiology 62: 357-358.
55. Sundararaghavan HG, Metter RB, Burdick JA (2010) Electrospun fibrous scaffolds with multiscale and photopatterned porosity. Macromol Biosci 10: 265-270.
56. Tongers J, Roncalli JG, Losordo DW (2008) Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 118: 9-16.
57. Uriel S, Labay E, Francis-Sedlak M, Moya ML, Weichselbaum RR, Ervin N, Cankova Z, Brey EM (2009) Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. Tissue Eng Part C 15: 309-321.
58. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, Milwid J, Kobayashi N, Tilles A, Berthiaume F, Hertl M, Nahmias Y, Yarmush ML, Uygun K (2010) Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16: 814-820.
59. Valentin JE, Turner NJ, Gilbert TW, Badylak SF (2010) Functional skeletal muscle formation with a biologic scaffold. Biomaterials 31: 7475-7484.
60. Wada MR, Inagawa-Ogashiwa M, Shimizu S, Yasumoto S, Hashimoto N (2002) Generation of different fates from multipotent muscle stem cells. Development 129: 2987-2995.
61. Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, Stupp SI (2011) Supra molecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci USA 108: 13438-13443.
62. Wolf MT, Daly KA, Reing JE, Badylak SF (2012) Biologic scaffold composed of skeletal muscle extra cellular matrix. Biomaterials 33: 2916-2925.
63. Yamamoto DL, Csikasz RI, Li Y, Sharma G, Hjort K, Karlsson R, Bengtsson T (2008) Myotube formation on micro-patterned glass: intracellular organization and protein distribution in C2C12 skeletal muscle cells. J Histochem Cytochem 56: 881-892.
64. Young DA, Ibrahim DO, Hu D, Christman KL (2011) Injectable hydrogel scaffold from decellularized human lipoaspirate. Acta Biomater 7: 1040-1049.
65. Zantop T, Gilbert TW, Yoder MC, Badylak SF (2006) Extra cellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. J Orthop Res 24: 1299-1309.